The randomized controlled trial on Mucosta ophthalmic suspension UD2% of effect in cataract surgery for dry eye patients

Not Applicable

• Conditions: Cataract patients with dry eye

• Registration Number: JPRN-UMIN000016986
• Lead Sponsor: The Ethical Review Board of Medical Association Ophthalmological Koseikai

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients complicated with any anterior segment disease other than dry eyes(including blepharitis, lagophthalmos,blepharospasm,and iritis ) (excluding past histories) 2. Patients unable to discontinue using contact lenses between the time of tests at the time of screening and the end of topical instillation of the study drug. 3. Patients with a lacrimal plug implanted or patients in whom a lacrimal opening plug dropped off within 3 months before the time of tests at the start of topical instillation. 4. Patients who perform a plan (hope) of the insertion of the Toric IOLs. 5. Patients with a history of ocular surface surgery within 12 months before tests at the start of topical instillation. 6. Patients with a severe eye disorder due to Stevens-Johnson syndrome or ocular pemphigoid. 7. Patients with hypersensitivity to any ingredient of the present study drug or reagent used in the present study. 8. Patients judged by the principal investigator/sub-investigator to be unable to be included in the study due to a previous or concurrent systemic disease. 9. Other patients judged by the principalinvestigator/sub-investigator to be not appropriate for safe implementation of the present study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified